Breaking News Instant updates and real-time market news.

MYL

Mylan

$35.94

-0.9 (-2.44%)

07:19
10/10/16
10/10
07:19
10/10/16
07:19

UBS remains constructive on Mylan despite governance controversy

UBS analyst Marc Goodman said he remains constructive on Mylan despite the controversy surrounding its corporate governance. Goodman cited the company's ability to execute, its surprise announcement of a EpiPen Medicaid lawsuit settlement and its updated guidance, which was better than feared. Goodman reiterated his Buy rating and lowered his price target to $60 from $66 on Mylan shares.

  • 09

    Nov

  • 28

    Mar

MYL Mylan
$35.94

-0.9 (-2.44%)

09/23/16
BERN
09/23/16
NO CHANGE
BERN
Mylan generic Epipen to lower EPS by about 10%, says Bernstein
Bernstein analyst Aaron Gal estimates that Mylan's decision to introduce a generic version of its EpiPen will create a drag of about 10% on its EPS. After viewing the Congressional hearings on the device, Gal continues to believe that a competitor to EpiPen will hit the market before the end of 2018. He keeps a $60 price target and Outperform rating on Mylan.
09/30/16
LEER
09/30/16
NO CHANGE
Target $45
LEER
Outperform
Mylan price target cut to $45 on lower EpiPen estimates at Leerink
Leerink analyst Jason Gerberry lowered his EpiPen sales forecasts by 33-45% from 2017-2021 in light of recent company updates, including its plan to launch an authorized generic of the emergency treatment later this year. While Mylan "appears on the right side of the law" regarding the latest Medicaid rebate controversy, Gerberry believes investors should consider the risk of a future settlement related to the issue. He cut his price target on Mylan shares to $45 from $55, but keeps an Outperform rating on the stock as he sees cash flows being sufficient to justify the current price.
10/04/16
JPMS
10/04/16
NO CHANGE
Target $52
JPMS
Overweight
Mylan price target lowered to $52 from $62 at JPMorgan
JPMorgan analyst Chris Schott lowered his price target for Mylan to $52 saying he remains cautious on the shares over the near-term given the ongoing Epipen controversy. The analyst, however, views the stock as "very inexpensive" and keeps an Overweight rating on the name. Schott sees a limited long-term impact to his thesis from the Epipen controversy and believes Mylan's generics business is underappreciated. He maintains an Overweight rating on the shares.
10/10/16
RAJA
10/10/16
UPGRADE
RAJA
Strong Buy
Mylan upgraded to Strong Buy from Market Perform at Raymond James

TODAY'S FREE FLY STORIES

QVCA

QVC Group

$24.61

0.1 (0.41%)

, QVCB

QVC Group

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
FBN Securities media analyst to hold a luncheon meeting »

Media Analyst Routh…

QVCA

QVC Group

$24.61

0.1 (0.41%)

QVCB

QVC Group

LVNTA

Liberty Ventures

$52.69

1.21 (2.35%)

GNCMA

General Communications

$36.81

0.97 (2.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 10

    Jul

ICON

Iconix Brand

$6.88

-0.01 (-0.15%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Iconix Brand management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

CIR

CIRCOR

$58.61

0.95 (1.65%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
CIRCOR management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

CUTR

Cutera

$26.55

1 (3.91%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Cutera management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 30

    Jun

  • 28

    Sep

EVLV

EVINE Live

$1.02

-0.02 (-1.92%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
EVINE Live management to meet with Craig-Hallum »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

FARM

Farmer Bros.

$31.15

1.05 (3.49%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Farmer Bros. management to meet with B. Riley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

AGNC

AGNC Investment

$21.54

-0.16 (-0.74%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
AGNC Investment management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

04:55
06/29/17
06/29
04:55
06/29/17
04:55
General news
Jobless Claims to be reported at 08:30 »

Week of 6/24 Jobless…

04:55
06/29/17
06/29
04:55
06/29/17
04:55
General news
Breaking General news story  »

Week of 6/25 Bloomberg…

04:55
06/29/17
06/29
04:55
06/29/17
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

NBIX

Neurocrine

$46.77

1.21 (2.66%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Neurocrine management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 29

    Jun

CBRL

Cracker Barrel

$167.46

0.74 (0.44%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Cracker Barrel management to meet with Maxim »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

CRNCY

Cairn Energy

$4.56

0.0998 (2.24%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Cairn Energy management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 30

    Jun

BAYRY

Bayer

$138.99

1.4 (1.02%)

, FMS

Fresenius Medical

$49.19

0.39 (0.80%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
UBS to hold a bus tour »

European Healthcare Bus…

BAYRY

Bayer

$138.99

1.4 (1.02%)

FMS

Fresenius Medical

$49.19

0.39 (0.80%)

RHHBY

Roche

$32.79

0.21 (0.64%)

NVS

Novartis

$85.25

-0.06 (-0.07%)

BPMUF

Basilea Pharmaceutica AG

$84.80

0.45 (0.53%)

GNMSF

Genmab

AZN

AstraZeneca

$34.35

-0.22 (-0.64%)

SHPG

Shire

$171.81

-0.1 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

  • 12

    Jul

  • 13

    Jul

  • 30

    Jul

CSV

Carriage Services

$26.85

0.06 (0.22%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Carriage Services management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 28

    Sep

WM

Waste Management

$73.52

0.41 (0.56%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Waste Management management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

FTV

Fortive

$64.41

1.04 (1.64%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Fortive has a conference call hosted by JPMorgan »

JPMorgan Analyst Tusa…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

RGA

Reinsurance Group

$128.86

2 (1.58%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Reinsurance Group management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

SRCL

Stericycle

$77.72

0.48 (0.62%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Stericycle management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 03

    Aug

RVLT

Revolution Lighting

$6.32

-0.05 (-0.78%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Revolution Lighting management to meet with Roth Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

04:55
06/29/17
06/29
04:55
06/29/17
04:55
General news
Real GDP to be reported at 08:30 »

Real GDP will be reported…

04:55
06/29/17
06/29
04:55
06/29/17
04:55
General news
Breaking General news story  »

Week of 6/28 Fed Balance…

04:55
06/29/17
06/29
04:55
06/29/17
04:55
General news
Breaking General news story  »

6-Month Bill Announcement…

BIIB

Biogen

$274.64

3.39 (1.25%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Biogen management to meet with Evercore ISI »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 25

    Jul

OXM

Oxford Industries

$62.76

0.92 (1.49%)

04:55
06/29/17
06/29
04:55
06/29/17
04:55
Conference/Events
Oxford Industries management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.